Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mintun, M. A.
Right arrow Articles by Katzenellenbogen, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mintun, M. A.
Right arrow Articles by Katzenellenbogen, J. A.

Radiology, Vol 169, 45-48, Copyright © 1988 by Radiological Society of North America


ARTICLES

Breast cancer: PET imaging of estrogen receptors

MA Mintun, MJ Welch, BA Siegel, CJ Mathias, JW Brodack, AH McGuire and JA Katzenellenbogen
Edward Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO 63110.

Thirteen patients with primary breast masses were studied with positron emission tomography (PET) and 16 alpha-[fluorine-18]-fluoroestradiol-17 beta. PET images demonstrated uptake of the labeled estrogen analog at sites of primary carcinomas and in several foci of axillary lymph node metastases, as well as in one distant metastatic site. There was excellent correlation between uptake within the primary tumor measured on the PET images and the tumor estrogen-receptor concentration measured in vitro after excision (r = .96). This technique may provide an in vivo method of assessing estrogen receptors in primary and metastatic breast cancers and thus guide management of this disease with antiestrogen chemotherapy.


This article has been cited by other articles:


Home page
RadiologyHome page
T. Tsujikawa, Y. Yoshida, T. Mori, T. Kurokawa, Y. Fujibayashi, F. Kotsuji, and H. Okazawa
Uterine Tumors: Pathophysiologic Imaging with 16{alpha}-[18F]fluoro-17{beta}-estradiol and 18F Fluorodeoxyglucose PET--Initial Experience
Radiology, August 1, 2008; 248(2): 599 - 605.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
E. E. Parent, C. S. Dence, T. L. Sharp, M. J. Welch, and J. A. Katzenellenbogen
7{alpha}-18F-Fluoromethyl-Dihydrotestosterone and 7{alpha}-18F-Fluoromethyl-Nortestosterone: Ligands to Determine the Role of Sex Hormone-Binding Globulin for Steroidal Radiopharmaceuticals
J. Nucl. Med., June 1, 2008; 49(6): 987 - 994.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
D. A. Mankoff, J. M. Link, H. M. Linden, L. Sundararajan, and K. A. Krohn
Tumor Receptor Imaging
J. Nucl. Med., June 1, 2008; 49(Suppl_2): 149S - 163S.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
L. M. Peterson, D. A. Mankoff, T. Lawton, K. Yagle, E. K. Schubert, S. Stekhova, A. Gown, J. M. Link, T. Tewson, and K. A. Krohn
Quantitative Imaging of Estrogen Receptor Expression in Breast Cancer with PET and 18F-Fluoroestradiol
J. Nucl. Med., March 1, 2008; 49(3): 367 - 374.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
A. L. Kesner, W.-A. Hsueh, N. L. Htet, B. S. Pio, J. Czernin, M. D. Pegram, M. E. Phelps, and D. H.S. Silverman
Biodistribution and Predictive Value of 18F-Fluorocyclophosphamide in Mice Bearing Human Breast Cancer Xenografts
J. Nucl. Med., December 1, 2007; 48(12): 2021 - 2027.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. A. Mankoff, J. F. Eary, J. M. Link, M. Muzi, J. G. Rajendran, A. M. Spence, and K. A. Krohn
Tumor-Specific Positron Emission Tomography Imaging in Patients: [18F] Fluorodeoxyglucose and Beyond
Clin. Cancer Res., June 15, 2007; 13(12): 3460 - 3469.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
J. P. Kanne, D. A. Mankoff, G. S. Baird, S. Minoshima, and R. B. Livingston
Gastric Linitis Plastica from Metastatic Breast Carcinoma: FDG and FES PET Appearances
Am. J. Roentgenol., June 1, 2007; 188(6): W503 - W505.
[Full Text] [PDF]


Home page
JCOHome page
W. A. Weber
Positron Emission Tomography As an Imaging Biomarker
J. Clin. Oncol., July 10, 2006; 24(20): 3282 - 3292.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
H. M. Linden, S. A. Stekhova, J. M. Link, J. R. Gralow, R. B. Livingston, G. K. Ellis, P. H. Petra, L. M. Peterson, E. K. Schubert, L. K. Dunnwald, et al.
Quantitative Fluoroestradiol Positron Emission Tomography Imaging Predicts Response to Endocrine Treatment in Breast Cancer
J. Clin. Oncol., June 20, 2006; 24(18): 2793 - 2799.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
G. J. Kelloff, K. A. Krohn, S. M. Larson, R. Weissleder, D. A. Mankoff, J. M. Hoffman, J. M. Link, K. Z. Guyton, W. C. Eckelman, H. I. Scher, et al.
The Progress and Promise of Molecular Imaging Probes in Oncologic Drug Development
Clin. Cancer Res., November 15, 2005; 11(22): 7967 - 7985.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
B. Van Den Bossche and C. Van de Wiele
Receptor Imaging in Oncology by Means of Nuclear Medicine: Current Status
J. Clin. Oncol., September 1, 2004; 22(17): 3593 - 3607.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
R. J. Bennink, G. van Tienhoven, L. J. Rijks, A. L. Noorduyn, A. G. Janssen, and G. W. Sloof
In Vivo Prediction of Response to Antiestrogen Treatment in Estrogen Receptor-Positive Breast Cancer
J. Nucl. Med., January 1, 2004; 45(1): 1 - 7.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
W. B. Eubank, D. A. Mankoff, H. J. Vesselle, J. F. Eary, E. K. Schubert, L. K. Dunnwald, S. K. Lindsley, J. R. Gralow, M. M. Austin-Seymour, G. K. Ellis, et al.
Detection of Locoregional and Distant Recurrences in Breast Cancer Patients by Using FDG PET
RadioGraphics, January 1, 2002; 22(1): 5 - 17.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
R. J. Bennink, L. J. Rijks, G. van Tienhoven, L. A. Noorduyn, A. G. Janssen, and G. W. Sloof
Estrogen Receptor Status in Primary Breast Cancer: Iodine 123-labeled cis-11{beta}-Methoxy-17{alpha}-iodovinyl Estradiol Scintigraphy
Radiology, September 1, 2001; 220(3): 774 - 779.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. E. Mortimer, F. Dehdashti, B. A. Siegel, K. Trinkaus, J. A. Katzenellenbogen, and M. J. Welch
Metabolic Flare: Indicator of Hormone Responsiveness in Advanced Breast Cancer
J. Clin. Oncol., June 1, 2001; 19(11): 2797 - 2803.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
D. A. Mankoff, L. M. Peterson, T. J. Tewson, J. M. Link, J. R. Gralow, M. M. Graham, and K. A. Krohn
[18F]Fluoroestradiol Radiation Dosimetry in Human PET Studies
J. Nucl. Med., April 1, 2001; 42(4): 679 - 684.
[Abstract] [Full Text]


Home page
J. Histochem. Cytochem.Home page
H.-A. Lehr, D. A. Mankoff, D. Corwin, G. Santeusanio, and A. M. Gown
Application of Photoshop-based Image Analysis to Quantification of Hormone Receptor Expression in Breast Cancer
J. Histochem. Cytochem., November 1, 1997; 45(11): 1559 - 1566.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1988 by the Radiological Society of North America.